295 related articles for article (PubMed ID: 36506064)
1. Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease.
Lyu J; Lin Q; Fang Z; Xu Z; Liu Z
Front Endocrinol (Lausanne); 2022; 13():1032557. PubMed ID: 36506064
[TBL] [Abstract][Full Text] [Related]
2. Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study.
Lu Y; Hu L; Song J; Wan J; Chen H; Yin J
BMC Endocr Disord; 2021 Nov; 21(1):231. PubMed ID: 34794397
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and gallstone disease.
Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
[TBL] [Abstract][Full Text] [Related]
4. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease.
Lee YC; Wu JS; Yang YC; Chang CS; Lu FH; Chang CJ
Scand J Gastroenterol; 2014 Aug; 49(8):1001-6. PubMed ID: 24989169
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship.
Arrese M; Cortés V; Barrera F; Nervi F
Curr Opin Gastroenterol; 2018 Mar; 34(2):90-96. PubMed ID: 29266009
[TBL] [Abstract][Full Text] [Related]
6. Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population.
Kichloo A; Solanki S; Haq KF; Dahiya D; Bailey B; Solanki D; Singh J; Albosta M; Wani F; Aljadah M; Shah H; Khan H; Jafri SM
World J Gastrointest Pathophysiol; 2021 Mar; 12(2):14-24. PubMed ID: 33815863
[TBL] [Abstract][Full Text] [Related]
7. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population.
Kwak MS; Kim D; Chung GE; Kim W; Kim YJ; Yoon JH
World J Gastroenterol; 2015 May; 21(20):6287-95. PubMed ID: 26034364
[TBL] [Abstract][Full Text] [Related]
8. An inverse association of weight and the occurrence of asymptomatic gallbladder stone disease in hypercholesterolemia patients: a case-control study.
Sheng B; Zhao Q; Ma M; Zhang J
Lipids Health Dis; 2020 Oct; 19(1):228. PubMed ID: 33097057
[TBL] [Abstract][Full Text] [Related]
9. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
[TBL] [Abstract][Full Text] [Related]
10. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
[TBL] [Abstract][Full Text] [Related]
12. Association Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome with Gallstone Disease, South Iran: A Population-Based Study.
Sepehrimanesh M; Niknam R; Ejtehadi F; Fattahi MR; Safarpour A
Diabetes Metab Syndr Obes; 2020; 13():1449-1458. PubMed ID: 32431528
[TBL] [Abstract][Full Text] [Related]
13. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.
Marventano S; Salomone F; Godos J; Pluchinotta F; Del Rio D; Mistretta A; Grosso G
Clin Nutr; 2016 Dec; 35(6):1269-1281. PubMed ID: 27060021
[TBL] [Abstract][Full Text] [Related]
14. Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: A systematic review and meta-analysis.
Shen SS; Gong JJ; Wang XW; Chen L; Qin S; Huang LF; Chen YQ; Ren H; Yang QB; Hu HD
Turk J Gastroenterol; 2017 Jan; 28(1):31-39. PubMed ID: 27991855
[TBL] [Abstract][Full Text] [Related]
15. Cholecystectomy versus central obesity or insulin resistance in relation to the risk of nonalcoholic fatty liver disease: the third US National Health and Nutrition Examination Survey.
Yue W; Sun X; Du T
BMC Endocr Disord; 2019 Sep; 19(1):95. PubMed ID: 31477078
[TBL] [Abstract][Full Text] [Related]
16. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
17. Is metabolic syndrome a risk factor in hepatectomy? A meta-analysis with subgroup analysis for histologically confirmed hepatic manifestations.
Murtha-Lemekhova A; Fuchs J; Feiler S; Schulz E; Teroerde M; Kalkum E; Klotz R; Billeter A; Probst P; Hoffmann K
BMC Med; 2022 Jan; 20(1):47. PubMed ID: 35101037
[TBL] [Abstract][Full Text] [Related]
18. Association between nonalcoholic fatty liver disease and gallstone risk in nonobese and lean individuals.
Kim NH; Kang JH; Kim HJ
Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):945-951. PubMed ID: 38652507
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Gallstone Disease and Cardiometabolic Risk Factors in Elderly People with Non-Alcoholic Fatty Liver Disease.
Hung MC; Chen CF; Tsou MT; Lin HH; Hwang LC; Hsu CP
Diabetes Metab Syndr Obes; 2020; 13():3579-3585. PubMed ID: 33116709
[TBL] [Abstract][Full Text] [Related]
20. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults.
Kwon YM; Oh SW; Hwang SS; Lee C; Kwon H; Chung GE
Am J Gastroenterol; 2012 Dec; 107(12):1852-8. PubMed ID: 23032980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
